Botanical species · safety record

Centranthus ruber

The EFSA Compendium of Botanicals holds 4 constituent measurements for Centranthus ruber. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Centranthus ruber (L.) DC.

4Constituent measurements

0Safety records

3Cited sources

0Licensed products (Canada)

Also recorded as

Kentranthus ruber (L.) Druce

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Erucic acid	Seed	—	≤ 10.89 Percent	Unspecified	No resolvable identifier
Erucic acid	Seed	—	≥ 10.84 Percent	Unspecified	No resolvable identifier
Gentioflavine	Unspecified	—	—	Nuclear Magnetic Resonance (NMR)	No resolvable identifier
Valtrate	Unspecified	—	—	Mass Spectroscopy and hyphenated methods without chromatography	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Dolya, V. S. Physicochemical properties of fatty oils of some species of the family Valerianaceae. Rastitel'nye resursy, 1986, p. 66-70.
Mollova, N., Khandzhieva, N., Popov, S. Chemical ionization mass spectrometry with amines as reactant gases. II. Amine chemical ionization mass spectrometry of diene valepotriates. Biomedical Environmental Mass Spectrometry, 1986, p. 159-166.
Marekov, N., Popov, S., Khandzhieva, N. Iridoids from Bulgarian medicinal plants. Khimiya i industriya, None, p. 132-135. [abstract].

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature